Literature DB >> 2332517

Histological and immunohistochemical study of hepatitis B virus in human immunodeficiency virus infection.

R D Goldin1, D E Fish, A Hay, J A Waters, M J McGarvey, J Main, H C Thomas.   

Abstract

Because the risk factors for human immunodeficiency virus (HIV) infection and hepatitis B (HBV) are similar and therefore coinfection is not uncommon, a detailed histological and immunohistochemical study of chronic hepatitis B infection in a group of 20 HIV positive Caucasian males (who did not have AIDS) and 30 HIV negative controls were undertaken. Using both the conventional histological classification and the Knodell histological activity index it was shown that HIV negative patients were more likely to have active disease and also more scarring than HIV positive patients. Hepatitis B surface antigen (HBsAg) expression was not significantly different between the two groups but expression of hepatitis Be antigen (HBeAg) and HBV-DNA polymerase was greater in those who were HIV positive. HIV positive patients are therefore more likely to have immunohistochemical markers of active viral replication, although histologically, liver disease is less severe. These findings have important implications for assessing the biopsy specimens in this group of patients and for treatment strategies aimed at improving their immune function.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2332517      PMCID: PMC502330          DOI: 10.1136/jcp.43.3.203

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Chronic hepatitis B in asymptomatic homosexual men with antibody to the human immunodeficiency virus.

Authors:  R P Perrillo; F G Regenstein; S T Roodman
Journal:  Ann Intern Med       Date:  1986-09       Impact factor: 25.391

2.  Identification of a dominant immunogenic epitope of the nucleocapsid (HBc) of the hepatitis B virus.

Authors:  J A Waters; T P Jowett; H C Thomas
Journal:  J Med Virol       Date:  1986-05       Impact factor: 2.327

Review 3.  Molecular and cellular pathology of hepatitis B.

Authors:  M A Gerber; S N Thung
Journal:  Lab Invest       Date:  1985-06       Impact factor: 5.662

4.  Effects of HIV superinfection on HBV replication in a chronic HBsAg carrier with liver disease.

Authors:  G Pastore; T Santantonio; L Monno; M Milella; N Luchena; G Angarano
Journal:  J Hepatol       Date:  1988-10       Impact factor: 25.083

5.  Acute and chronic hepatitis revisited. Review by an international group.

Authors: 
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

6.  Effect of human immunodeficiency virus (HIV) infection on chronic hepatitis B hepatic viral antigen display.

Authors:  J A McDonald; S Harris; J A Waters; H C Thomas
Journal:  J Hepatol       Date:  1987-06       Impact factor: 25.083

7.  Distribution of HBcAg in hepatitis B detected by immunoperoxidase staining with three different preparations of anti-HBc antibodies.

Authors:  S Kakumu; M Arao; K Yoshioka; Y Tsutsumi; M Inoue
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

8.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.

Authors:  R G Knodell; K G Ishak; W C Black; T S Chen; R Craig; N Kaplowitz; T W Kiernan; J Wollman
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

9.  The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers.

Authors:  K Krogsgaard; B O Lindhardt; J O Nielson; P Andersson; P Kryger; J Aldershvile; J Gerstoft; C Pedersen
Journal:  Hepatology       Date:  1987 Jan-Feb       Impact factor: 17.425

  9 in total
  10 in total

1.  Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection.

Authors:  E Bierhoff; H P Fischer; E Willsch; J Rockstroh; U Spengler; H H Brackmann; J Oldenburg
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

Review 2.  Sexually transmitted hepatitis: a review.

Authors:  R J Gilson
Journal:  Genitourin Med       Date:  1992-04

3.  Hepatitis B virus-human immunodeficiency virus co-infection in France: a cross-sectional multicentre study.

Authors:  D Sène; S Pol; L Piroth; C Goujard; P Dellamonica; J Moussali; D Rey; V Loustaud-Ratti; L Alric; M Chousterman; F Borsa-Lebas; O Boucher; D Séréni; P Cacoub
Journal:  Epidemiol Infect       Date:  2006-07-25       Impact factor: 2.451

4.  Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA.

Authors:  G R Foster; A M Ackrill; R D Goldin; I M Kerr; H C Thomas; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

Review 5.  Management of hepatitis B in patients coinfected with the human immunodeficiency virus.

Authors:  R Lessells; C Leen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-04-27       Impact factor: 3.267

6.  Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection.

Authors:  J Judy Chang; Sunee Sirivichayakul; Anchalee Avihingsanon; Alex J V Thompson; Peter Revill; David Iser; John Slavin; Supranee Buranapraditkun; Pip Marks; Gail Matthews; David A Cooper; Stephen J Kent; Paul U Cameron; Joe Sasadeusz; Paul Desmond; Stephen Locarnini; Gregory J Dore; Kiat Ruxrungtham; Sharon R Lewin
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

7.  Iron overload in multiply transfused patients who are HIV seropositive.

Authors:  R D Goldin; M Wilkins; S Dourakis; J Parkin; R Lindley
Journal:  J Clin Pathol       Date:  1993-11       Impact factor: 3.411

8.  HIV and Hepatitis Virus Infection.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-04       Impact factor: 3.663

9.  HIV/HBV Co-Infections: Epidemiology, Natural History, and Treatment: A Review Article.

Authors:  R Ranjbar; A Davari; M Izadi; N Jonaidi; S M Alavian
Journal:  Iran Red Crescent Med J       Date:  2011-12-01       Impact factor: 0.611

10.  Hepatitis B virus (HBV)-specific T-cell responses to recombinant HBV core protein in patients with normal liver function and co-infected with chronic HBV and human immunodeficiency virus 1 (HIV-1).

Authors:  Xin Zhang; Hanqian Xing; Xia Feng; Haiping Zhang; Yi Wang; Huiping Yan
Journal:  Virol J       Date:  2013-07-12       Impact factor: 4.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.